Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (4), 485-488
- https://doi.org/10.1016/0192-0561(88)90137-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- Inhibition of natural killer cell function by Marijuana componentsJournal of Toxicology and Environmental Health, 1987
- Interleukin 2 induction of interferon-gamma mRNA synthesis.The Journal of Immunology, 1986
- The Effect of Delta-9-Tetrahydrocannabinol and 11-Hydroxy-Delta-9-Tetrahydrocannabinol on T-Lymphocyte and B-Lymphocyte Mitogen ResponsesJournal of Immunopharmacology, 1985
- Effects of Δ9-Tetrahydrocannabinol, Cannabinol and Cannabidiol on the Immune System in MicePharmacology, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Potential Therapeutic Usefulness of MarijuanaAnnual Review of Pharmacology and Toxicology, 1980
- Plasma membrane inhibition of macromolecular precursor transport by THCBiochemical Pharmacology, 1979